ストックスクリーナーアプリを入手
8.215
0.30%
-0.025
Armata Pharmaceuticals Inc (ARMP) 最新ニュース
Is Armata Pharmaceuticals Inc. a cyclical or defensive stockJuly 2025 Drop Watch & Safe Investment Capital Preservation Plans - mfd.ru
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP) Short Interest Update - MarketBeat
MACD Signal: What analysts say about Armata Pharmaceuticals Inc stockJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - baoquankhu1.vn
Armata Pharmaceuticals FY2025 EPS Boosted by HC Wainwright - MarketBeat
Aug Closing: What is RADCOM Ltds debt to equity ratioMarket Movers & High Accuracy Swing Trade Signals - baoquankhu1.vn
AI Stocks: Can Armata Pharmaceuticals Inc grow without external fundingMarket Volume Summary & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Armata Pharmaceuticals (ARMP) price target increased by 33.33% to 12.24 - MSN
Phage Therapy Market Set to Witness Significant Growth - openPR.com
Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Stock Price Up 2%Time to Buy? - MarketBeat
Armata Extends Innoviva Credit, Warrants and Voting Pact - TipRanks
Armata Pharmaceuticals (ARMP) Surges 103.2%: Is This an Indication of Further Gains? - MSN
Will Armata Pharmaceuticals Inc. stock gain from lower inflationQuarterly Market Summary & Comprehensive Market Scan Reports - bollywoodhelpline.com
Published on: 2026-01-19 10:14:54 - baoquankhu1.vn
Armata Pharmaceuticals (ARMP) Price Target Increased by 33.33% to 12.24 - Nasdaq
Block Trades: Is Armata Pharmaceuticals Inc stock a smart retirement pickTrade Risk Assessment & Growth Focused Stock Pick Reports - baoquankhu1.vn
Armata Wins FDA Support to Advance Bacteriophage to Phase 3 - TipRanks
Armata Pharmaceuticals Advances AP-SA02 to Phase 3 Study - TradingView — Track All Markets
C O R R E C T I O N -- Armata Pharmaceuticals, Inc./ – Company Announcement - Financial Times
ARMP Stock Quote - richtv.io
Why Armata Pharmaceuticals Inc. (TG1N) stock is upgraded to buyJuly 2025 Weekly Recap & Target Return Focused Picks - ulpravda.ru
What valuation multiples suggest for Armata Pharmaceuticals Inc. stock2025 Technical Overview & Consistent Income Trade Recommendations - ulpravda.ru
Armata Pharmaceuticals, Inc. Common Stock (NY: ARMP - FinancialContent
Will Armata Pharmaceuticals Inc. stock benefit from upcoming earnings reportsMarket Trend Report & Entry and Exit Point Strategies - Улправда
Will Armata Pharmaceuticals Inc. stock continue dividend increases2025 Price Targets & Community Consensus Trade Alerts - Улправда
Trade Recap: Will Armata Pharmaceuticals Inc. stock deliver long term returnsJuly 2025 Catalysts & Accurate Entry/Exit Alerts - Улправда
Can Armata Pharmaceuticals Inc. stock attract ESG capital inflowsMarket Risk Summary & Scalable Portfolio Growth Methods - ulpravda.ru
Will Armata Pharmaceuticals Inc. stock maintain dividend yield2025 Geopolitical Influence & Advanced Technical Signal Analysis - Улправда
Will Armata Pharmaceuticals Inc. stock pay special dividendsMarket Sentiment Review & Real-Time Stock Movement Alerts - Улправда
About Us | Oil & Gas JournalArmata Pharmaceuticals, Inc. Common Stock (NYSE:ARMP) Detailed Stock Data - FinancialContent
Will Armata Pharmaceuticals Inc. stock outperform energy sector in 20252026 world cup usa national team round of 16 goalkeepers counter attacking tactical prediction expert opinion - ulpravda.ru
Jones Trading initiates coverage of Armata Pharmaceuticals (ARMP) with buy recommendation - MSN
Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Coverage Initiated by Analysts at Jones Trading - Defense World
Is Armata Pharmaceuticals (ARMP) Stock Outpacing Its Medical Peers This Year? - MSN
Jones Trading Initiates Coverage on Armata Pharmaceuticals (ARMP - GuruFocus
Jones Trading Initiates Coverage on Armata Pharmaceuticals (NYSEAMERICAN:ARMP) - MarketBeat
Jones Trading initiates coverage on Armata Pharmaceuticals stock with Buy rating - Investing.com Canada
Published on: 2026-01-05 08:37:29 - moha.gov.vn
Gap Down: Will Armata Pharmaceuticals Inc stock maintain dividend yieldMarket Growth Report & Risk Controlled Stock Pick Alerts - moha.gov.vn
ARMATA PHARMACEUTICALS INC(NYSEARCA:ARMP) stock News - Chartmill
Day Trade: Is Armata Pharmaceuticals Inc stock among top earnings playsLayoff News & Fast Exit and Entry Strategy Plans - moha.gov.vn
Will Armata Pharmaceuticals Inc stock maintain dividend yieldMarket Risk Summary & Growth Focused Entry Reports - moha.gov.vn
Pharma News: Will Armata Pharmaceuticals Inc stock gain from lower inflation2025 Market WrapUp & Real-Time Buy Signal Alerts - moha.gov.vn
Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Trading 2.7% HigherStill a Buy? - MarketBeat
Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Trading 2.7% Higher – Still a Buy? - Defense World
Aug Closing: Will Armata Pharmaceuticals Inc TG1N stock benefit from sector leadershipJuly 2025 Fed Impact & Consistent Growth Equity Picks - moha.gov.vn
Is Armata Pharmaceuticals Inc. stock trading near support levelsJuly 2025 Price Swings & Fast Moving Market Watchlists - DonanımHaber
Can Armata Pharmaceuticals Inc. stock deliver surprise earnings beatDip Buying & Safe Capital Growth Tips - Улправда
Can Armata Pharmaceuticals Inc. (TG1N) stock sustain double digit ROEJuly 2025 Catalysts & Accurate Entry/Exit Alerts - Улправда
Why Armata Pharmaceuticals Inc. stock attracts global investorsWeekly Profit Recap & Long-Term Growth Portfolio Plans - Улправда
Armata Pharmaceuticals Earnings Notes - Trefis
Why Armata Pharmaceuticals Inc. stock attracts wealthy investors2025 Buyback Activity & Free Real-Time Market Sentiment Alerts - Улправда
How Armata Pharmaceuticals Inc. stock reacts to bond yields2025 Volume Leaders & High Yield Equity Trading Tips - bolumsonucanavari.com
Is Armata Pharmaceuticals Inc. stock dividend growth reliableShare Buyback & Stepwise Trade Signal Implementation - DonanımHaber
Merger Talk: Can Armata Pharmaceuticals Inc. stock attract ESG capital inflowsWeekly Trade Review & Long-Term Growth Stock Strategies - DonanımHaber
Published on: 2025-12-19 11:47:18 - DonanımHaber
0.66%
大文字化:
|
ボリューム (24 時間):